Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Cirius Therapeutics

Cirius Therapeutics

Cirius Therapeutics is a company developing an insulin sensitizer for the treatment of non-alcoholic steatohepatitis.

OverviewStructured DataIssuesContributorsActivity
Is a
Company
Company
Organization
Organization
Board of Directors
‌
Dennis Fenton
0
‌
Bob Baltera
0
‌
Daniel Estes
0
‌
Robert L. Zerbe
0
‌
Nilesh Kumar
0
‌
Michael Jandernoa
0
CAGE Code
8KMW5
0
CEO
‌
Bob Baltera
0
CIK Number
1,702,956
0
Company Operating Status
Active
Contact Page URL
ciriustx.com/contact/
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...apeutics
DUNS Number
095144153
0
Full Address
161 E. Michigan Avenue 4th Floor Kalamazoo, MI 49007 USA
0
12651 High Bluff Drive Suite 150 San Diego, CA 92130 USA
0
Industry
Drug metabolism
Drug metabolism
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Life science
Life science
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Pharmaceutical industry
Pharmaceutical industry
Enzyme kinetics
Enzyme kinetics
Pharmacokinetics
Pharmacokinetics
•••
Investors
Hopen Life Science Ventures
Hopen Life Science Ventures
Frazier Healthcare Partners
Frazier Healthcare Partners
IRS Number
820,928,811
0
Latest Funding Round Date
April 11, 2017
Latest Funding Type
Series A
Series A
Location
San Diego
San Diego
0
Kalamazoo, Michigan
Kalamazoo, Michigan
0
Patents Assigned (Count)
1
Pitchbook URL
pitchbook.com/profiles...159372-55
Place of Incorporation
Delaware
Delaware
0
SIC Code
2,834
0
Total Funding Amount (USD)
40,000,000
Official Website
ciriustx.com

Find more companies like Cirius Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo